Lab study aims to find best backup drug for Post-Birth bleeding
NCT ID NCT06285409
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study uses small samples of uterine tissue from 32 women having planned C-sections to test which backup drug best contracts the uterus after carbetocin has been given. The goal is to improve treatment for severe bleeding after childbirth. The research is done in the lab, not on patients directly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTPARTUM HEMORRHAGE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mount Sinai Hospital
RECRUITINGToronto, Ontario, M5G1X5, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple calcium tablet help prevent postpartum bleeding?
- Medical glue vs. internal bleeding: a new hope?
- Which drug stops Post-Birth bleeding better? a Head-to-Head test
- Could a simple calcium injection prevent dangerous bleeding after childbirth?
- Blood-Clotting showdown: which device best guides bleeding care in High-Risk patients?
- Simple C-Section techniques could slash postpartum bleeding risk